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Understanding the tissue interactions that induce pancreatic progenitor cells from the embryonic endoderm provides insights into congenital
malformations, tissue repair, and differentiating stem cells to a pancreatic fate. The specification of pancreatic progenitors within the dorsal
endodermal epithelium has been thought to involve two phases of mesodermal interactions; first with the lateral plate mesoderm and notochord
and then with aortic endothelial cells. Afterwards, branching morphogenesis of the pancreatic bud is induced by Isl-1-positive dorsal mesenchyme
cells, whose growth is stimulated by factors in the circulation. Using mouse genetic models and embryo tissue explants, we show that the aortic
endothelium and dorsal mesenchyme each possess an additional role in pancreatic induction, prior to the branching morphogenesis step.
Specifically, we find that aortic endothelial cells promote the survival of nearby, Isl-1-positive dorsal mesenchyme, independently of factors from
the circulation. Furthermore, we find that FGF10 signaling from the mesenchyme cells maintains Ptf1a expression in the dorsal pancreatic bud
and appears genetically redundant with a role for the transcription factor gene HNF6 in promoting the induction of Pdx-1-positive dorsal
endoderm. Together, these studies reveal a relay pathway from aortic endothelium to dorsal mesenchyme and then to the endoderm, along with
functions of the dorsal mesenchyme that promote the initial differentiation of the dorsal pancreatic endoderm, prior to organ morphogenesis.
D 2005 Elsevier Inc. All rights reserved.Keywords: Pancreas; Endothelium; Mesenchyme; Organogenesis; FGF10; SpecificationIntroduction
In embryonic development, the pancreas, liver, lung, and
thyroid emerge from the gut endoderm, the latter being one of
the three germ layers formed during gastrulation. Studies of
vertebrate organogenesis have revealed that endodermal inter-
actions with different mesodermal cell types pattern the
endodermal epithelium into progenitor cell domains and
promote local organ outgrowth (Hogan and Zaret, 2002). The
purpose of this study was to determine how inductive
interactions with different mesoderm cell types are coordinated
to initiate pancreatic development. Understanding the process-0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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pancreatic program and undergo morphogenetic development
should provide insight into tissue regeneration, oncogenesis,
and stem cell differentiation.
In separate dorsal and ventral– lateral domains of the
endoderm, the HNF6 transcription factor gene is required for
timely initiation of Pdx-1 expression (Jacquemin et al., 2003),
thereby marking progenitor cells of the pancreas and duode-
num (Jonsson et al., 1994; Offield et al., 1996; Ahlgren et al.,
1997; Gu et al., 2002). A subset of these cells then expresses
other transcription factors, marking both endocrine and
exocrine progenitors (Kawaguchi et al., 2002; Chiang and
Melton, 2003; Jensen et al., 2004). The cells become columnar,
thicken the endodermal epithelium into a tissue bud, and
proliferate into the surrounding stromal tissue, thereby initiat-
ing pancreas morphogenesis (Slack, 1995).
The dorsal pancreatic endoderm domain is induced by
phases of tissue interactions (Wessels and Cohen, 1967; Wells90 (2006) 189 – 199
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2001; Horb and Slack, 2001; Kumar et al., 2003). In mouse
embryos around 8.5 days gestation (E8.5), activin-related
signaling from the notochord, a mesodermal derivative,
represses sonic hedgehog expression in the midgut endoderm
and thereby permits the expression of Pdx-1 and a pancreatic
fate in the dorsal endoderm (Kim et al., 1997; Hebrok et al.,
1998). Subsequently, around E8.75–9.0 (12–20 somite pairs;
12–20S), aortic endothelial cells, another mesodermal deriv-
ative, interact with the dorsal, Pdx-1+ endoderm and induce the
essential transcription factor gene Ptf1a (Yoshitomi and Zaret,
2004). flk-1/ embryos, which lack endothelial cells and a
vasculature (Shalaby et al., 1995), fail to induce Ptf1a and
develop a dorsal pancreas bud. The ability of isolated, wild-
type aortae to induce Ptf1a in co-cultured explants of flk-1/
dorsal endoderm shows that the endothelial induction of Ptf1a
in the dorsal endoderm is specific to the cells’ interactions and
not to factors in the bloodstream (Yoshitomi and Zaret, 2004).
After specification, morphogenetic induction of the pancre-
atic buds also involves phases of tissue interactions. Explant
recombination studies showed that budding of dorsal pancre-
atic tissue into the stroma, around E9.5, requires interactions
with dorsal mesenchyme cells (Golosow and Grobstein, 1962;
Wessels and Cohen, 1967; Spooner et al., 1970; Pictet et al.,
1972; Ahlgren et al., 1996), and subsequent proliferation and
branching morphogenesis of the pancreatic cells require
FGF10 expressed in the mesenchyme (Bhushan et al., 2001;
Ye et al., 2005). Embryos deficient for Isl-1, a transcription
factor gene normally expressed by dorsal pancreatic mesen-
chyme and other cell types (Pfaff et al., 1996; Cai et al., 2003),
exhibit a marked deficiency in dorsal mesenchyme cells and a
failure to develop a dorsal pancreatic bud (Ahlgren et al.,
1997). Similarly, embryos deficient for N-cadherin exhibit
apoptosis of the dorsal mesenchyme and a failure to develop a
dorsal pancreatic bud (Esni et al., 2001). These embryos also
have an abnormal aortic endothelium and deficient blood
circulation (Edsbagge et al., 2005). Restoration of aortic
integrity and circulatory function, in embryos expressing N-
cadherin from a cardiac muscle-specific promoter, results in
dorsal mesenchyme survival and pancreatic budding, indicat-
ing that a systemic factor is involved (Luo et al., 2001;
Edsbagge et al., 2005). This factor may be sphingosine-1-
phosphate (S1P), a signaling phospholipid found in the blood,
for which dorsal mesenchyme and endothelial cells express
receptors. Exogenous S1P can stimulate the growth of wild-
type dorsal mesenchyme and endothelial cells in explant
cultures (Edsbagge et al., 2005). Thus, S1P signaling to
mesenchyme, possibly indirectly, via local endothelial cells,
supports mesenchyme survival, which in turn promotes
pancreatic budding and FGF10-induced proliferation.
Although the lack of endothelial cells in flk-1/ embryos is
associated with a failure of Ptf1a induction and a failure in
dorsal pancreas budding (Yoshitomi and Zaret, 2004), the
failure in budding is not due to the absence of Ptf1a
expression, since Ptf1a/ embryos develop an initial dorsal
pancreatic bud (Krapp et al., 1998; Kawaguchi et al., 2002).
Thus, endothelial cells contribute to a phase of dorsal pancreasdevelopment that succeeds Ptf1a induction. We therefore
investigated a functional connection between aortic endothelial
cells and local mesenchyme cells in promoting dorsal
pancreatic morphogenesis. This led to the unexpected discov-
ery of a relay pathway whereby endothelial cells directly
support mesenchyme cells. Further investigation of the early
contributions of the mesenchymal cells to pancreatic develop-
ment revealed a mechanism whereby the cells promote the
initial differentiation of dorsal pancreatic endoderm. We
suggest that knowledge of this network can be useful for
diverse areas of pancreas biology.
Methods
Embryo isolation and genotyping
Flk-1 lacZ mice (gift of J. Rossant) and Fgf10 mice (gift of N. Itoh and S.
Kato) were generated as described (Sekine et al., 1999; Shalaby et al., 1995).
Hnf6 mice were described (Jacquemin et al., 2000). Noon of the day of the
vaginal plug was considered E0.5. Embryos were harvested at E8.5–10.5 and
staged according to pairs of somites. Embryos were dissected free of
extraembryonic membranes, and the heads were used for genotyping. As the
pancreatic phenotype of all heterozygous embryos was normal (Jacquemin et
al., 2000; Shalaby et al., 1995), these embryos and wild-type embryos were
designated as controls.
In situ hybridization, immunohistochemistry, and TUNEL analysis
Embryos were prepared and analyzed as described (Jacquemin et al., 2003;
Yoshitomi and Zaret, 2004). In situ hybridization on sections was performed
using a digoxigenin-labeled fgf10 probe (gift of N. Itoh), and labeling was
detected with the TSA Biotin System (NEN). Tissue sections were reacted with
mouse monoclonal anti-Isl-1 antibody (Iowa Univ. hybridoma bank) at a 1/
2000 dilution or with anti-Pdx-1 antibody (gift from C. Wright) at a 1/5000
dilution in 0.1 blocking buffer at 4-C overnight. Primary antibody was
detected with Vectastain Elite ABC kit (Vector, Burlingame, CA) using Vector
SG (Vector, Burlingame, CA) or Alexa-Fluor 594 labeled secondary antibodies
(Molecular Probes, Eugene, OR). Sections were counterstained with eosin Y or
4V,6-diamino-2 phenylindole (DAPI). Whole mount immunohistochemistry was
performed as described (Jacquemin et al., 2003) using affinity-purified rabbit
anti-Pdx-1 antibody (gift of H. Edlund). TUNEL analysis with fluorescein was
performed with the In situ cell death detection kit (Roche Applied Science).
Tissue dissection and recombinant explants
Embryo tissues were dissected as described (Gittes and Galante, 1993;
Yoshitomi and Zaret, 2004). Isolated E9.5 aortae were washed with PBS to
remove possibly contaminating blood cells. The dissected tissues were cultured
according to Lammert et al. (2001) with the following modifications: The
tissues were recombined, embedded in growth-factor reduced Matrigel (Becton
Dickinson), and cultured with DMEM media supplemented with 10% calf
serum, 1 penicillin– streptomycin (GIBCO BRL) at 37-C with 5% CO2 for
the indicated periods. FGF-10 was from R&D Systems. Media were changed
every 2 days of culture.
RT-PCR analysis
RNAwas isolated from tissues and explants by using Qiagen RNeasy Micro
Kits. PCR analysis and actin primers were as described by Yoshitomi and Zaret
(2004). Other primers were TBP sense 5V-ACCCTTCACCAATGACTCC-
TATG-3V, antisense 5V-ATGATGACTGCAGCAAATCGC-3V, 190-bp product;
Pdx-1 sense 5V-AAGAGCCCAACCGCGTCCAGC-3V, antisense 5V-
AGTACGGGTCCTCTTGTTTTC-3V 125-bp product; Isl-1 sense 5V-GAGCTG-
GAGACCCTCTCAGTC-3V, antisense 5V-GCGCATCTGGCCGAGGGTTGG-
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sense 5V-TGAGCTGTTTTTCATCAGTCCAG-3V, 99-bp product. Cycle step
titrations were taken for all PCR analyses, and single points in the exponential
range, normalized to actin, were chosen for the figures.
Results
Selective loss of dorsal mesenchyme cells in flk-1/ embryos
When the aorta first interacts with the dorsal endoderm, at
the 12–20 somite pair stage (E8.75–9.0), mesenchyme cells
begin to accumulate lateral to the endoderm (Wessels and
Cohen, 1967). By the 20–25 somite pair stages (E9.5), when
the aorta moves dorsally, away from the endoderm, Isl-1-
positive mesenchyme cells accumulate between the aorta and
the dorsal endoderm (Ahlgren et al., 1997). Although
mesenchymal cell survival requires circulating signals via
the aorta (Edsbagge et al., 2005), we wished to test the
possibility that aortic endothelial cells directly affect dorsal
pancreatic mesenchyme cells. We therefore first analyzed the
developing pancreatic bud at the 24S stage (E9.5) in wild-
type and flk-1/ embryos, which lack endothelial cells and
the aorta (Yoshitomi and Zaret, 2004). The dorsal endoderm
cells of flk-1/ embryos were weakly Pdx-1-positive and
remained in an immature shape (Fig. 1B), in contrast to the
columnar wild-type cells at this stage (Fig. 1A). Notably, the
mesenchyme that is normally dorsal to the dorsal pancreatic
bud at this stage (Fig. 1A) was virtually absent in the flk-1/
embryos (Fig. 1B), with nearly an empty space between the
Pdx-1-positive dorsal endoderm and the neural tube (Fig. 1B).
By contrast, the ventral and lateral mesenchyme appearedFig. 1. Dorsal Isl-1+ mesenchyme is deficient in flk-1/ embryos. Pdx-1 (A–D) a
embryos at 24 (A–D), 26 (E–H) somite stages. Control embryos have extensive do
and a distinct dorsal pancreatic bud (A, E). flk-1/ embryos at 26S have Isl-1+ mes
(F), but lack Isl-1+ mesenchymal cells dorsally (B, F). In flk-1/ embryos, the ventr
unaffected (C, D).unaffected in flk-1/ embryos, and the ventral midgut
endoderm cells expressed high levels of Pdx-1, assumed their
normal columnar shape, and initiated the formation of a tissue
bud (Figs. 1C, D) (Yoshitomi and Zaret, 2004).
To assess the nature of the dorsal mesenchyme cells in flk-
1/ embryos, we performed immunostaining for Isl-1
(Ahlgren et al., 1997). Wild-type embryos at 26S contained
Isl-1-positive cells dorsal and lateral to the dorsal pancreatic
bud, as well Isl-1-positive pancreatic bud cells (Fig. 1E), as
expected (Ahlgren et al., 1997; Pfaff et al., 1996). flk-1/
embryos at 26S had Isl-1-positive cells lateral to the gut tube
and within the dorsal endoderm, but the rare mesenchyme cells
dorsal to the gut tube were Isl-1-negative (Fig. 1F). We
conclude that in the flk-1/ embryos, mesenchymal cells
appear lateral to the gut tube, but not dorsally.
Selective apoptosis of local dorsal mesenchyme cells in
flk-1/ embryos
We next investigated the means by which Isl-1-positive
mesenchymal cells failed to appear dorsal to the Pdx-1-positive
endoderm in flk-1/ embryos. We noted that the dorsal, Isl-1-
negative cells were small and round, compared to the Isl-1+
cells in control embryos (Figs. 1A, B, E, F), suggesting that
they might be apoptotic. At 16–19S (E8.75–9.0), when the
aorta normally begins to pull away from the endoderm and Isl-
1-positive mesenchyme cells accumulate near the dorsal–
lateral endoderm, and begin to appear dorsally (Ahlgren et al.,
1997; Pfaff et al., 1996; and see Figs. 4C, F, I below), there
were few or no TUNEL-positive cells in dorsal midgutnd Isl-1 (E–F) immunostaining of transverse sections of control and flk-1/
rsal and lateral Isl-1+ mesenchyme cells (brownish-purple staining nuclei, (E))
enchyme cells lateral to the gut tube and Isl-1+ cells within the dorsal endoderm
al pancreatic bud is surrounded by normal amounts of mesenchyme cells and is
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in flk-1/ embryos at 16S, the mesenchyme cells located
dorsal–lateral to the gut tube (Fig. 2C, d.m., right green arrow),
as well as dorsal to it (Fig. 2C, d.m., left green arrow), began to
appear TUNEL-positive, and by 19S, virtually all such
mesenchyme cells were TUNEL-positive, including cells
lateral to the dorsal region of the gut tube (Fig. 2D, right
green arrow), indicating apoptosis. And as we noted above, by
24S, mesenchymal cells were virtually absent from the dorsal
midgut endoderm, whereas normally, the region is filled with
Isl-1-positive mesenchyme cells (Figs. 1B, F; Ahlgren et al.,
1997; Pfaff et al., 1996). Thus, the timeline for mesenchymal
failure is between the 16S and 24S stages, i.e., E9.0–9.5, and it
includes both Isl-1-negative cells that are dorsal to the gut tube
and a subset of Isl-1-positive cells that are normally dorsal–
lateral to the gut tube and that normally appear dorsally after
the 16–19S stages (also see Figs. 4C, F, I, below).Fig. 2. Presence of aorta supports dorsal mesenchyme cell survival. (A–F) TUNE
embryos. At 16S, flk-1/ dorsal mesenchyme cells begin to apoptose (C) and by 19S
flk-1/ embryos (F). d.m. and v.m., dorsal and ventral mesenchyme; n.t.; neural tub
cranial to the hindgut are apoptotic in flk-1/ embryos. TUNEL analysis and DAP
transverse sections at different anterior–posterior positions of a 19S flk-1/ embrTo determine the specificity with which apoptotic cells
appear dorsally in flk-1/ embryos, we assessed the extent
to which apoptotic cells could be detected in the foregut,
midgut, and hindgut (Figs. 2G, I, K, M). We used Pdx-1
immunohistochemistry to confirm the midgut position
relative to the others (Figs. 2H, J, L). Apoptotic cells
could be seen in the dorsal mesenchyme of flk-1/
embryos at the level of the foregut (Fig. 2G, light blue
cells denoted by blue arrows) but not in the cardiac tube,
despite the fact that cardiac muscle precursor cells are Isl-1-
positive (Cai et al., 2003). No apoptotic cells could be
found in the dorsal mesenchyme at the level of hindgut
(Fig. 2K), where, in wild-type embryos, the aorta is
normally narrow and thin. These results indicate that the
survival of mesenchyme cells which are normally close to
the aorta, rostral to the hindgut, are selectively supported by
the presence of the aorta.L analysis on transverse sections of control (A, B, E) and flk-1/ (C, D, F)
, most have done so (D). By contrast, no apoptotic cells can be seen ventrally in
e, d. endo and v. endo, dorsal and ventral endoderm. (G–M) Mesenchymal cells
I stain (G, I, and K) and Pdx-1 IHC and DAPI stain (H, J, and L) on adjacent
yo, as shown in panel M.
P. Jacquemin et al. / Developmental Biology 290 (2006) 189–199 193The selectivity of the dorsal mesenchyme’s requirement for
the vasculature is striking, in that there was not an increased
number of TUNEL-positive cells in the dorsal or ventral
endoderm (Figs. 2E, F), neural tube (Figs. 2C, D, G, I, K, n.t.),
somites (Fig. 2D, so.; and data not shown), or notochord (Figs.
2C, D, G; below n.t.) in flk-1/ embryos, and these tissues are
normally as close to the aorta as many of the dorsal
mesenchyme cells. We conclude that the presence of the
vascular system specifically supports local mesenchyme cells,
both Isl-1-positive and -negative, whereas diverse other nearby
cell types are unaffected.
Aorta cells support dorsal mesenchyme survival in the absence
of circulating factors
Although previous studies indicated that circulating
factors support dorsal mesenchyme survival (Edsbagge et
al., 2005), the studies left open the possibility that the effect
was either secondary to circulating factors required for
endothelial maturation or acting in conjunction with direct
interactions with endothelial cells (Lammert et al., 2001;
Matsumoto et al., 2001; Yoshitomi and Zaret, 2004). To
investigate these possibilities, we performed tissue recombi-
nation studies. The dorsal mesenchyme and aortae were
dissected from midsections of 20–25S wild-type embryos,
the aortae were washed to remove blood, and the resultant
mesenchyme was shown to be Pdx-1-negative and thus free
of dorsal pancreatic endoderm cells (Figs. 3A–C). TheFig. 3. Isolated aorta maintains the growth of Isl-1-positive dorsal mesenchymal cell
PCR analysis shows that Pdx-1-positive endodermal cells do not contaminate the dis
tissues. (D, E, G, H, J, K), whole mount phase contrast views. (F, I, L) Immunohistoc
with the aorta maintain abundant Isl-1-positive cells (F, shown by arrows).dorsal mesenchyme and aortae were then cultured individ-
ually or together for 8 days and then subjected to Isl-1
immunostaining. Explants of the aorta alone contained a few
Isl-1-positive cells (Figs. 3J–L, arrows in L), probably due
to a low level of contamination of Isl-1-positive dorsal
mesenchyme cells in the dissected aortic tissue (Fig. 3B).
Dorsal mesenchyme explants cultured alone exhibited poor
survival of Isl-1-positive cells (Figs. 3G–I, arrows in I). By
contrast, mesenchyme explants cultured with aorta exhibited
abundant Isl-1-positive cells (Figs. 3D–F, arrows in F).
Thus, the aortic endothelium can directly promote the
survival of Isl-1-positive mesenchymal cells, independent of
the endoderm and independent of aortal function as a
conduit for factors in the bloodstream.
Expression of Fgf10 by Isl-1-positive dorsal mesenchyme cells
well prior to the branching morphogenesis stage of pancreatic
differentiation
In light of the classical organogenic view of dorsal
mesenchyme cells (Wessels and Cohen, 1967; Pictet et al.,
1972), our in vitro explant studies suggested that endothelial
cells would promote dorsal pancreas development indirectly,
by supporting dorsal mesenchyme cells. The loss of dorsal
pancreatic mesenchyme in flk-1/ embryos was associated
with a failure of the dorsal, pdx-1-positive endoderm to enter a
budding and branching, morphogenetic phase (Fig. 1). This
hypothesis led us to investigate growth signals produced by thes in vitro. (A, B) Tissues being dissected from an E9.5 control embryo. (C) RT-
sected dorsal mesenchymal tissue. (D–L) In vitro explant cultures of designated
hemistry for Isl-1 on explant sections. Only the mesenchymal explants cultured
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circulating factors. Fgf10 was previously shown to be expressed
at E9.5 in the pancreatic mesenchyme and to be necessary for
Pdx-1-positive endoderm proliferation and branching morpho-
genesis (Bhushan et al., 2001). Also, we note that in those
studies, the size of the Pdx-1-positive domain in Fgf10/
embryos appeared smaller than wild type at E10.5, prior to
branching morphogenesis (Bhushan et al., 2001; Ye et al.,
2005). These observations suggested to us a possible earlier
signaling role for Fgf10, prior to branching morphogenesis.
Indeed, analysis of sectioned embryos showed that Fgf10
is expressed in mesenchyme cells when they first appear
lateral to the Pdx-1-positive region of the midgut (15S to 17S
stage; Figs. 4A, B, D, E; note red hybridization grains to the
FGF10 probe). Shortly afterwards, starting at the 21–26S
stages, Fgf10-positive mesenchyme cells surround the dorsal
pancreatic bud, prior to branching morphogenesis (Figs. 4G,
H, J, K). Fgf10 was not expressed around the ventral
pancreas bud at E9.5 (26S, Figs. 4M, N). While technical
issues prevented colabeling of individual sections, an analysis
of sequential serial sections through the dorsal region of wild-
type embryos revealed a remarkable concordance between
Fgf10 and Isl-1 expression in the dorsal mesenchyme cells, at
all stages tested (Figs. 4B, C, E, F, H, I). Taken together,
these results indicate that the aortic endothelium promotes
survival of Isl-1- and fgf10-positive mesenchymal cells
around the dorsal pancreas.
Functional redundancy of Fgf10 and Hnf6 genes in pancreatic
specification
To investigate the role of FGF10 in early pancreas
development, we analyzed Fgf10/ embryos. At the 19S
and 23S stages, pancreas development in Fgf10/ embryos
was not affected (compare Figs. 5A, B with D, E), indicating
that pancreas specification was normal. At the 27S stage (Figs.
5C, F), the size of the dorsal pancreas was reduced in Fgf10/
embryos, which is consistent with deficient morphogenesis as
described earlier (Bhushan et al., 2001). Therefore, analysis of
Fgf10/ embryos did not suggest a role for Fgf10 in
expression of pancreatic genes in the endoderm.
However, the timing of dorsal mesenchyme Fgf10 expres-
sion, starting around the 20S stage in normal embryos,
correlates with the time of delayed onset of Pdx-1 expression
in Hnf6/ embryos, from the 11S stage to the ¨20S stage
(Jacquemin et al., 2003). This suggested that Fgf10 may play a
role in inducing Pdx-1 in the endoderm in the absence of Hnf6.
To test this hypothesis, we generated Hnf6//Fgf10/
double null embryos. Remarkably, the Hnf6//Fgf10/
embryos exhibited an apparently complete defect in pancre-
atic specification. That is, Hnf6//Fgf10/ embryos failed
to activate Pdx-1 expression dorsally or ventrally, even at
later stages (Figs. 5G–J for up to 27S; later stages, data not
shown), and did not generate a pancreatic bud. Embryo
section analysis showed the dorsal pancreatic mesenchyme
was intact in the double homozygous embryos (Figs. 5K, L),
showing that the failure in pancreatic specification andbudding was not due to an absence of mesenchyme. Also,
in Hnf6/ embryos, Fgf10 expression was unaffected (Figs.
5M, N), showing that FGF10 is produced at the time and
place when delayed Pdx-1 expression is induced in such
embryos. These findings reveal a functional redundancy for
the Hnf6 and Fgf10 genes, whereby they insure the
specification of the pancreas.
FGF10 enhances the expression of Ptf1a
Ptf1a is expressed in progenitors of all pancreas cells and
is necessary for the development of all descendant cell types
(Krapp et al., 1998; Kawaguchi et al., 2002). We previously
found that Ptf1a is normally induced in the pancreatic buds
at the 15–18 somite stage, which precedes the appearance of
Isl-1+ cells dorsally (Yoshitomi and Zaret, 2004). Interest-
ingly, we discovered that the expression of Ptf1a is not
properly maintained in Fgf10/ embryos, in that at the 26
somite stage, midgut regions containing the pancreatic buds
were markedly deficient in Ptf1a mRNA, relative to mRNAs
for a control Tbp gene or Pdx-1 (Fig. 6A). This suggested
that FGF10 from pancreatic mesenchyme cells might
normally help maintain Ptf1a expression.
To investigate this possibility more directly, we isolated
dorsal pancreatic bud explants and treated them with FGF10.
We previously showed that embryonic tissue explants of
dorsal, Pdx-1-positive endoderm at ¨8 somites (E8.5) would
induce the de novo expression of the pancreatic specification
gene Ptf1a (Kawaguchi et al., 2002) if they were cultured in
vitro in the presence of aorta tissue (Yoshitomi and Zaret,
2004). This initial induction of Ptf1a by the aorta occurs in
the apparent absence of dorsal mesenchyme cells. We now
find that when dorsal pancreatic bud explants from E9.0–9.5
(20–25S) are cultured for 2 days, they maintain very low
levels of Ptf1a expression (Fig. 6B, lane 1). The E9.0–9.5
explants contain Isl-1+ mesenchyme cells (Fig. 6B, lane 1)
and express low but detectable levels of FGF10 mRNA
(data not shown). However, when the explants are treated
with increasing concentrations of FGF10, they exhibit
markedly induced levels of Ptf1a mRNA, despite the
apparent decrease in Isl-1 expression or Isl-1 expressing
cells (Fig. 6B, lanes 24).
To assess whether FGF10 acts directly upon the endoderm
cells or is dependent upon Isl-1+ mesenchyme cells or
endothelial cells in the explants, we repeated the assay using
dorsal pancreatic endoderm isolated from flk-1/ embryos.
These explants exhibited low levels of Ptf1a expression and
little or no Isl-1 expression (Fig. 6B, lane 5); the latter was
due to a lack of mesenchyme and endothelial cells (see Figs.
1–3 and Yoshitomi and Zaret, 2004). However, in separate
experiments (Fig. 6B, lanes 6–8 and data not shown),
addition of FGF10 to the flk-1/ pancreatic endoderm
cultures increased the expression of Ptf1a. It is likely that
the level of induction was less than seen with wild-type
cultures because of the relatively weak survival of dorsal
endoderm in the absence of the endothelium and mesen-
chyme (see Figs. 1B, F). In summary, FGF10 can stimulate
Fig. 4. Fgf10 is expressed in the mesenchyme surrounding the dorsal pancreatic endoderm. Serial sections from wild-type embryos were stained by
immunohistochemistry to detect Pdx-1 (A, D, G, J, M) and Isl-1 (C, F, I, L, O), and by in situ hybridization to detect Fgf10 expression (B, E, H, K, N). Fgf10
expression is first found in lateral mesenchyme cells (B, E). Starting at the 21S stage, Fgf10+ mesenchyme cells surround the dorsal pancreatic bud (H, K). The
Fgf10+ cells are Isl-1+ (compare B, E, H, K with C, F, I, L). Some Fgf10 is detected in the mesenchyme around the gut tube, but not around the ventral pancreatic bud
(M, N). The ventral pancreas mesenchyme did not express Isl-1 (O). Blue arrows point to Fgf10 expression, green arrows to Isl-1 expression. l.m. and d.m., lateral
and dorsal mesenchyme.
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Fig. 5. Failure of pancreatic specification in Fgf10//Hnf6/ double homozygous embryos. (A–J) Whole mount Pdx-1 immunohistochemistry of embryo
midsections. Black arrows, dorsal pancreatic anlagen; white arrows, ventral pancreatic anlagen. (K, L) Section analysis of 27S embryo midguts from the Pdx-1 whole
mounts showing an intact dorsal mesenchyme both in control and Fgf10//Hnf6/ double homozygous embryos. The yellow material marked with an asterisk in
panel L is nonspecific debris trapped in the gut tube. No Pdx-1-positive cells or pancreatic bud emerges in Fgf10//Hnf6/ embryos, even after 36S (data not
shown). Serial sections stained for Pdx-1 by immunohistochemistry, and for Fgf10 by in situ hybridization showed that Fgf10 expression is detected in dorsal
mesenchyme, even in the absence of HNF-6 (M, N).
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Discussion
Taken together, our data are consistent with endothelial cells
having a secondary, indirect inductive influence on pancreatic
differentiation that succeeds the endothelial cells’ initial
influence on pancreatic specification (Lammert et al., 2001;
Yoshitomi and Zaret, 2004). We find that endothelial cells
support dorsal mesenchyme cells in the midgut that are either
Isl-1+ or Isl-1 (Figs. 1, 2). The Isl-1-positive population waspreviously found to be crucial for dorsal pancreatic develop-
ment (Ahlgren et al., 1997), and here, we show that these cells
first appear lateral to the midgut by 15 somites and then
proximal to the dorsal Pdx-1-positive cells at around 20 somites
(Fig. 4). Our tissue explant assays showed that endothelial cells
directly promote the survival of the Isl-1-positive mesenchymal
cells, independent of the endoderm and factors in the circulation
(Fig. 3). Although circulating factors, including sphingosine-1-
phosphate, have recently been shown to also promote dorsal
midgut mesenchymal cell survival (Edsbagge et al., 2005), we
suggest that such factors work either in parallel with the
endothelium, secondarily through it, or both.
Fig. 6. FGF10 stimulation of Ptf1a expression. (A) RT-PCR of midgut mRNAs
containing the dorsal and ventral pancreatic buds from E9.5 (26S) embryos of
the designated Fgf10 genotypes. ‘‘ctrl’’ is with water input; ‘‘+ctrl’’ is with
cDNA from E14.5 pancreases. The data show that Fgf10 is necessary to
maintain Ptf1a expression. (B) RT-PCR of dorsal pancreatic bud explants of the
designated Flk-1 genotypes cultured for 2 days in the presence of the
designated concentrations of FGF10 in the medium. The data show that FGF10
induces Ptf1a expression in the endoderm in the absence of endothelium and of
significant amounts of Isl-1-positive mesenchyme cells in the explant.
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remarkably specific, in that diverse other tissues that are
normally near the aorta and the endothelium, such as the
endoderm, neural tube, notochord, and somites, were not
apoptotic in flk-1/ embryos, which lack a vasculature (Figs.
1, 2). The dorsal mesenchyme cells are also different from the
ventral, septum transversum mesenchyme cells, which con-
tribute to hepatic endoderm growth (Hentsch et al., 1996) but
exhibit no dependence upon endothelial cells (Matsumoto et
al., 2001). The lack of dependence of the mammalian ventral
pancreatic bud or the zebrafish pancreatic bud on the
endothelium (Field et al., 2003; Yoshitomi and Zaret, 2004)
further underscores the specific dependence of the dorsal
mesenchyme and dorsal pancreas bud on the aorta. Various
other examples of direct endothelial cell interactions are
emerging (Serluca et al., 2002; LeCouter et al., 2003; Shen
et al., 2004), giving rise to the view that different types of
endothelium possess distinct inductive capabilities.
We found that the lateral and dorsal Isl-1+ mesenchyme cells
express FGF10 at around the 15 and 20 somite stages,
respectively, which is earlier than had been previously
appreciated for this cell domain (Fig. 4). We found that
Fgf10 is necessary at 26 somites to maintain the expression of
Ptf1a, a transcription factor gene needed to complete pancre-
atic specification (Kawaguchi et al., 2002). Furthermore,
FGF10 treatment of dorsal pancreatic endoderm explants from
flk-1/ embryos was sufficient to increase the expression of
Ptf1a. Based on the timing of normal Ptf1a induction, the
ability of isolated aorta tissue to induce Ptf1a in the absence of
mesenchyme (Yoshitomi and Zaret, 2004), and the later
appearance of dorsal Isl-1+ mesenchyme cells (Fig. 4, thisstudy), we do not believe that the mesenchyme cells promote
normal Ptf1a induction. Rather, mesenchyme cells may
contribute to the maintenance of Ptf1a expression. In wild-
type explants (Fig. 6), traces of endogenous FGF10 in culture
(data not shown) were insufficient to robustly maintain Ptf1a
expression (Fig. 6), and the ability of exogenous FGF10 to
stimulate Ptf1a expression may reflect the need for optimal
FGF10 concentrations to maintain Ptf1a expression.
Previous work had shown that in the absence of HNF-6,
dorsal pancreas specification is delayed until the 20S stage
(Jacquemin et al., 2003). We now show that the dorsal
pancreatic specification in the Hnf6/ background requires
Fgf10 signaling from the mesenchyme (Fig. 5). Fgf10, and
dorsal pancreatic mesenchyme cells, may possess an unex-
pected, compensatory activity in terms of insuring dorsal
pancreatic specification. Interestingly, ectopic Fgf10 expres-
sion in Pdx-1-positive cells has been found to promote the
proliferation of pancreatic progenitor cells and thereby inhibit
pancreatic differentiation (Hart et al., 2003; Norgaard et al.,
2003). One explanation for these latter results, in light of our
findings, is that the FGF10-enhanced progenitor state may
include the expression of Ptf1a, which is normally down-
regulated in endocrine cells after its expression in all pancreatic
progenitors (Kawaguchi et al., 2002). Regardless of this
speculation, it is interesting to consider how an exogenous
factor such as FGF10 can compensate for early pancreas
program genes that are normally dependent upon Hnf6
expression for activity. Presumably, FGF10 activates pathways
and transcription factors within undifferentiated endoderm cells
that bypass the proper temporal activity of diverse earlier
signals that effect the induction of a dorsal Pdx-1-positive
endoderm and pancreatic bud formation (Murtaugh and
Melton, 2003).
Our discovery of the role of Fgf10 in Hnf6 deficient
embryos shows that the dorsal endoderm is either continu-
ously subject to pancreatic specification signals that remain
present during the 7–20S period, or continuously adaptable to
environmental signals that can be re-interpreted for specifica-
tion in an Hnf6/ background. The plasticity of the
endoderm during this period, and the complexity of relay
networks, such as from the endothelium to the mesenchyme,
underscore the depth to which gut tissue specification has
evolved. Far more work is needed to understand these
pathways before we can prospectively program cells for
biomedical needs with confidence.
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